Lonza Group
LONN.SWHealthcare · Diagnostics & Research · CH603.80CHF+3.14%
StratDeckLonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and...
Price · Past year
Loading chart…
Checks
- Pass: Price trending up The figures
- Pass: Sales growing faster than its peers The figures
- Fail: Not making a profit The figures
- Pass: Analysts rate it a buy The figures
- Fail: Costs more than similar companies The figures
- Not known: Last quarter's profit forecast not available
Share
Keep researching
Where next from LONN.SW
Other stocks you may like
Fundamentals
Yahoo FinanceShowHide
What's happening?
LONN.SW is beating Healthcare this month The figures
- 1D
- +3.14%
- 7D
- +7.17%
- 1M
- +12.40%
- 3M
- +4.97%
- 6M
- +14.77%
- YTD
- +13.45%
What is the market expecting?
StratDeckCosts more than similar companies, and analysts expect the price to rise The figures
Value score vs Healthcare peers
25- Fwd P/E27.212
- P/B5.244
- Yield0.8%27
- P/E40.022
- Rev growth+11.2%79
Is the business delivering?
Sales are growing faster than at similar companies, and profit per share is up The figures
Earnings by quarter
Latest quarter 0.74
- 0.74Jul05—
How does it compare?
Nearest in Healthcare on valueStratDeckLONN.SW is worse value than most Healthcare stocks The figures
What happens next?
Reports next on 27 Jan, in 102 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.